American Healthcare REIT Beats Q2 Earnings, but Its Dividend Engine Is Leaking Cash

If you hold American Healthcare REIT (AHR) for its quarterly check, you should probably look at something that actually pays you enough to matter. The stock just reported Q2 earnings that beat consensus, raised full-year guidance, and declared another $0.25 dividend. All of that is true. None of it answers the question that should come first: can this payout last?

Here's the short answer. At a trailing payout ratio of 216%, AHR is distributing more than twice what its GAAP earnings produce. That kind of ratio doesn't signal confidence — it signals a dividend funded by accounting mechanics, not surplus cash. And when you look at the cash-flow statement, the warning gets louder.

The headline beats mask a cash-flow squeeze

Q2 EPS came in at $0.16 versus a consensus of roughly $0.14. Revenue was $671 million, above the $645 million estimate. The company raised its full-year 2026 guidance. On paper, that's a solid quarter.

But the operating cash flow tells a different story. Over the trailing twelve months, AHR generated $315 million in operating cash flow — fine on its own. Capital expenditures, however, consumed $278 million of that. The result: free cash flow of $37 million, down 73% year-over-year. In REIT language, free cash flow is what's left after you fund the maintenance and growth that keeps the properties income-producing. When it collapses, the dividend sits on a shrinking foundation.

The capex isn't waste. AHR has been on an aggressive acquisition binge, spending over $950 million on new skilled nursing and senior housing facilities in 2025. That strategy drives top-line revenue — and it explains the Q2 revenue beat. But it also explains why free cash flow has cratered. You can't spend three-quarters of your operating cash flow on new assets and expect the old dividend structure to hold without strain.

The yield isn't worth the trouble

Here's where the income investor should step back before investing more mental energy. AHR's trailing dividend yield is 1.75%. Forward, it's 1.83%. That's not a yield — it's an afterthought.

For context, a diversified portfolio of investment-grade bonds currently yields in the 4% to 5% range, with far less business risk. The stock trades at 105 times trailing earnings. You're paying a premium growth multiple for a dividend that would take over five years just to pay for one share of stock. If the payout ratio stays above 200%, that multiple has to contract before the math works in your favor.

AHR has been paying dividends for only one consecutive year as a public REIT. It's not an old guard with a 20-year track record of riding out downturns. It's a newer income vehicle still figuring out its payout discipline — and right now, the discipline isn't there.

The balance sheet isn't broken, but it's levered

Total debt sits at $2.08 billion against $3.52 billion of equity — a debt-to-equity ratio of 43%. That's manageable for a healthcare REIT, which benefits from relatively stable rental contracts with skilled nursing operators. Net debt of $1.51 billion (after $119 million in cash) is reasonable in isolation.

But leverage doesn't get dangerous only through debt levels. It gets dangerous when debt funds growth that doesn't return cash fast enough to service it. AHR's debt is financing acquisitions, and those acquisitions are absorbing the free cash flow the dividend needs. The structural risk isn't bankruptcy — it's a dividend that can't keep up with the growth story it was supposed to fund.

What would change the picture

AHR isn't a bad business. The skilled nursing real estate niche is genuinely underserved, and the company's Trilogy Health Services operating model — combining skilled nursing and assisted living under one roof — has produced improving margins. Management raised full-year 2026 guidance, which suggests they believe acquisition integration will drive efficiency.

The dividend becomes defensible if free cash flow recovers as acquisitions stop eating cash and start producing steady rental income. A payout ratio that falls back below 100% would change the character of this stock entirely. At that point, the 1.75% yield wouldn't be an insult — it would be a conservative starting point with room to grow.

But that recovery is a forward promise, not a current fact. And income investors shouldn't fund their retirement on promises.

Portfolio role: skip it, for now

AHR is a growth story wearing an income disguise. If you believe in the skilled nursing real estate thesis, there are better ways to capture it without taking on a 216% payout ratio and a 1.75% yield. Omega Healthcare (OHI), which operates in the same space, offers a 5.4% yield and — while its own payout ratio of 125% isn't perfect — at least generates meaningful income now.

For the retiree building a cash-flow system, AHR doesn't earn a seat until its dividend is covered by actual free cash flow and the yield is high enough to matter. The company raised guidance and beat EPS. Those are nice headlines. But the cash-flow engine is the only thing that keeps the dividend alive when sentiment fades.

Wait for the free cash flow to recover and the payout ratio to come down. Until then, there are income vehicles that don't ask you to trust their accounting to fund your quarterly budget.